1.
Konté K, Swinkels DW, Budde IK, Nur E, Biemond BJ. Safety and efficacy of human apotransferrin infusion in patients with β-thalassemia intermedia: the AIM study. haematol [Internet]. 2025Jan.1 [cited 2025Apr.26];110(1):183-6. Available from: https://haematologica.org/article/view/haematol.2024.285045